FDA Approved: TREMFYA — Original Application (Janssen Biotech, Inc.)

View source ↗

Summary

The FDA approved TREMFYA (guselkumab) from Janssen Biotech as the original application for the treatment of moderate to severe plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

ORIG AP for TREMFYA (GUSELKUMAB)